Additionally, women with SHBG < 30 nmol/L were 4.75 times more likely to be diagnosed with NAFLD than those with normal SHGB levels (HR = 4.75, 95% CI 2.44–9.25, p < 0.001) [13]. This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.